
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Naringenin is a key flavonoid aglycone found in grapefruit, derived from its glycoside naringin, and is recognized for its potent antioxidant, anti-inflammatory, and metabolic properties. Its primary mechanisms involve inhibiting specific cardiac ion channels and various cytochrome P450 (CYP) enzymes, impacting drug metabolism and cellular processes.

Reported Benefits (Provisional)
Origin & History

Naringenin is a potent flavonoid primarily found in grapefruits (*Citrus paradisi*), which originated in Barbados as a hybrid of pomelo and sweet orange. This bioactive compound contributes to the tart flavor of grapefruits and offers extensive health benefits, including antioxidant, anti-inflammatory, and metabolic-regulating properties. It is highly valued in functional nutrition for its therapeutic potential in improving cardiovascular health, supporting liver detoxification, and regulating glucose metabolism.
Research Narrative (Provisional)
Extensive research, including in vitro, animal, and some human clinical studies, investigates Naringenin's antioxidant, anti-inflammatory, and metabolic-regulating properties. Studies explore its potential in cardiovascular health, liver support, and glucose metabolism. Further robust human clinical trials are needed to fully establish its therapeutic applications and optimal dosages.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Naringenin (flavonoid) - Other Polyphenols
Reported Mechanism (Provisional)
Naringenin, released from naringin by gut hydrolysis, primarily acts through inhibiting cardiac ion channels like hERG, with reported IC50 values ranging from 36.5 μM in HEK cells to 102.6 μM. Additionally, it strongly inhibits various cytochrome P450 (CYP) enzymes, including CYP3A4, CYP2C9, CYP2C19, and CYP19, thereby influencing drug metabolism and toxin bioactivation.
Clinical Narrative (Provisional)
Extensive research on Naringenin, encompassing in vitro and animal models, highlights its antioxidant, anti-inflammatory, and metabolic-regulating properties, exploring its potential in cardiovascular health, liver support, and glucose metabolism. While some human clinical studies exist, these are not consistently robust, lacking specific sample sizes and clear outcome data in the provided research. Consequently, further comprehensive and well-designed human trials are needed to fully establish its clinical efficacy and therapeutic applications.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







